cyproterone acetate has been researched along with Cognition Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gardiner, RA; Green, HJ; Headley, BC; Mactaggart, PN; Nicol, DL; Pakenham, KI; Swanson, C; Watson, RB; Yaxley, J | 1 |
| Gardiner, RA; Green, HJ; Headley, BC; Mactaggart, PN; Nicol, DL; Pakenham, KI; Swanson, CE; Watson, RB; Yaxley, J | 1 |
| Bloomfield, DJ; Edginton, TL; Jenkins, VA; Shilling, VM | 1 |
3 trial(s) available for cyproterone acetate and Cognition Disorders
| Article | Year |
|---|---|
Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Androgen Antagonists; Antineoplastic Agents, Hormonal; Cognition Disorders; Cyproterone Acetate; Drug Combinations; Goserelin; Humans; Leuprolide; Male; Middle Aged; Prostatic Neoplasms | 2002 |
Quality of life compared during pharmacological treatments and clinical monitoring for non-localized prostate cancer: a randomized controlled trial.
Topics: Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Cognition Disorders; Cyproterone Acetate; Goserelin; Humans; Leuprolide; Male; Prostatic Neoplasms; Quality of Life; Sexual Dysfunction, Physiological; Stress, Psychological | 2004 |
Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study.
Topics: Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Cognition Disorders; Cyproterone Acetate; Goserelin; Humans; Intelligence; Male; Memory Disorders; Middle Aged; Neoadjuvant Therapy; Pilot Projects; Prostatic Neoplasms; Quality of Life; Speech Disorders; Surveys and Questionnaires | 2005 |